194 related articles for article (PubMed ID: 33819921)
1. Tumor infiltrating lymphocyte signature is associated with single nucleotide polymorphisms and predicts survival in esophageal squamous cell carcinoma patients.
Suo C; Chen H; Binczyk F; Zhao R; Fan J; Yang X; Yuan Z; Kreil D; Łabaj P; Zhang T; Lu M; Jin L; Polańska J; Chen X; Ye W
Aging (Albany NY); 2021 Apr; 13(7):10369-10386. PubMed ID: 33819921
[TBL] [Abstract][Full Text] [Related]
2. Tumour infiltrating lymphocytes correlate with improved survival in patients with esophageal squamous cell carcinoma.
Jiang D; Liu Y; Wang H; Wang H; Song Q; Sujie A; Huang J; Xu Y; Zeng H; Tan L; Hou Y; Xu C
Sci Rep; 2017 Mar; 7():44823. PubMed ID: 28322245
[TBL] [Abstract][Full Text] [Related]
3. Identification and characterization of prognosis-related genes in the tumor microenvironment of esophageal squamous cell carcinoma.
Qu J; Zhao Q; Yang L; Ping Y; Zhang K; Lei Q; Liu F; Zhang Y
Int Immunopharmacol; 2021 Jul; 96():107616. PubMed ID: 34162127
[TBL] [Abstract][Full Text] [Related]
4. Intronic polymorphisms in genes LRFN2 (rs2494938) and DNAH11 (rs2285947) are prognostic indicators of esophageal squamous cell carcinoma.
Wang J; Wang Q; Wei B; Zhou Y; Qian Z; Gao Y; Chen X
BMC Med Genet; 2019 May; 20(1):72. PubMed ID: 31053115
[TBL] [Abstract][Full Text] [Related]
5. Single nucleotide polymorphism rs13042395 in the SLC52A3 gene as a biomarker for regional lymph node metastasis and relapse-free survival of esophageal squamous cell carcinoma patients.
Tan HZ; Wu ZY; Wu JY; Long L; Jiao JW; Peng YH; Xu YW; Li SS; Wang W; Zhang JJ; Li EM; Xu LY
BMC Cancer; 2016 Jul; 16():560. PubMed ID: 27472962
[TBL] [Abstract][Full Text] [Related]
6. Associations of ATM Polymorphisms With Survival in Advanced Esophageal Squamous Cell Carcinoma Patients Receiving Radiation Therapy.
Du Z; Zhang W; Zhou Y; Yu D; Chen X; Chang J; Qiao Y; Zhang M; Huang Y; Wu C; Xiao Z; Tan W; Lin D
Int J Radiat Oncol Biol Phys; 2015 Sep; 93(1):181-9. PubMed ID: 26094126
[TBL] [Abstract][Full Text] [Related]
7. Tumor-Infiltrating CD4+ Lymphocytes Predict a Favorable Survival in Patients with Operable Esophageal Squamous Cell Carcinoma.
Chen K; Zhu Z; Zhang N; Cheng G; Zhang F; Jin J; Wu J; Ying L; Mao W; Su D
Med Sci Monit; 2017 Sep; 23():4619-4632. PubMed ID: 28949934
[TBL] [Abstract][Full Text] [Related]
8. The differences of immunologic and TP53 mutant phenotypes between synchronous and metachronous head and neck cancer and esophageal cancer.
Chen TC; Wu CT; Wang CP; Lou PJ; Ko JY; Chang YL
Oral Oncol; 2020 Dec; 111():104945. PubMed ID: 32769036
[TBL] [Abstract][Full Text] [Related]
9. Identification of a nomogram based on long non-coding RNA to improve prognosis prediction of esophageal squamous cell carcinoma.
Li W; Liu J; Zhao H
Aging (Albany NY); 2020 Jan; 12(2):1512-1526. PubMed ID: 31978896
[TBL] [Abstract][Full Text] [Related]
10. Clinical utility of the systemic immune-inflammation index for predicting survival in esophageal squamous cell carcinoma after radical radiotherapy.
Wang Y; Lyu J; Jia H; Liang L; Xiao L; Liu Y; Liu X; Li K; Chen T; Zhang R; Zhang H; Tang C; Li T
Future Oncol; 2021 Jul; 17(20):2647-2657. PubMed ID: 34008415
[TBL] [Abstract][Full Text] [Related]
11. Differential Cumulative Risk of Genetic Polymorphisms in Familial and Nonfamilial Esophageal Squamous Cell Carcinoma.
Suo C; Qing T; Liu Z; Yang X; Yuan Z; Yang YJ; Fan M; Zhang T; Lu M; Jin L; Chen X; Ye W
Cancer Epidemiol Biomarkers Prev; 2019 Dec; 28(12):2014-2021. PubMed ID: 31562207
[TBL] [Abstract][Full Text] [Related]
12. Genetic variants of DNA repair genes predict the survival of patients with esophageal squamous cell cancer receiving platinum-based adjuvant chemotherapy.
Zhou F; Zhu M; Wang M; Qiu L; Cheng L; Jia M; Xiang J; Wei Q
J Transl Med; 2016 May; 14(1):154. PubMed ID: 27246611
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of tumor-infiltrating immune cells and PD-L1 expression in esophageal squamous cell carcinoma.
Jiang Y; Lo AWI; Wong A; Chen W; Wang Y; Lin L; Xu J
Oncotarget; 2017 May; 8(18):30175-30189. PubMed ID: 28404915
[TBL] [Abstract][Full Text] [Related]
14. Genetic Variants in EGFR/PLCE1 Pathway Are Associated with Prognosis of Esophageal Squamous Cell Carcinoma after Radical Resection.
Wang YL; Yuan Y; Luo XX; Hu GY; Gong P
Curr Med Sci; 2019 Jun; 39(3):385-390. PubMed ID: 31209807
[TBL] [Abstract][Full Text] [Related]
15. PARP1 Gene Polymorphisms and the Prognosis of Esophageal Cancer Patients from Cixian High-Incidence Region in Northern China.
Zhou RM; Li Y; Wang N; Niu CX; Huang X; Cao SR; Huo XR
Asian Pac J Cancer Prev; 2020 Oct; 21(10):2987-2992. PubMed ID: 33112558
[TBL] [Abstract][Full Text] [Related]
16. A genetic variant in CDKN2A/2B locus was associated with poor prognosis in patients with esophageal squamous cell carcinoma.
Ghobadi N; Mehramiz M; ShahidSales S; Rezaei Brojerdi A; Anvari K; Khazaei M; Rezayi M; Sadegh Khorrami M; Joudi-Mashhad M; Ramshini H; Ahmadi-Simab S; Moradi A; Hassanian SM; Ghayour-Mobarhan M; Boroushaki MT; Ferns GA; Avan A
J Cell Physiol; 2019 Apr; 234(4):5070-5076. PubMed ID: 30238987
[TBL] [Abstract][Full Text] [Related]
17. TIM-3 polymorphism is involved in the progression of esophageal squamous cell carcinoma by regulating gene expression.
Cui SJ; Li Y; Zhou RM; Liu L; Cao SR; Huang X; Huo XR; Wang N
Environ Mol Mutagen; 2021 Apr; 62(4):273-283. PubMed ID: 33723872
[TBL] [Abstract][Full Text] [Related]
18. Increased intraepithelial CD3+ T-lymphocytes and high PD-L1 expression on tumor cells are associated with a favorable prognosis in esophageal squamous cell carcinoma and allow prognostic immunogenic subgrouping.
Jesinghaus M; Steiger K; Slotta-Huspenina J; Drecoll E; Pfarr N; Meyer P; Konukiewitz B; Bettstetter M; Wieczorek K; Ott K; Feith M; Langer R; Weichert W; Specht K; Boxberg M
Oncotarget; 2017 Jul; 8(29):46756-46768. PubMed ID: 28657901
[TBL] [Abstract][Full Text] [Related]
19. Integrative stemness characteristics associated with prognosis and the immune microenvironment in esophageal cancer.
Yi L; Huang P; Zou X; Guo L; Gu Y; Wen C; Wu G
Pharmacol Res; 2020 Nov; 161():105144. PubMed ID: 32810627
[TBL] [Abstract][Full Text] [Related]
20. Identification of microRNAs as novel biomarkers for esophageal squamous cell carcinoma: a study based on The Cancer Genome Atlas (TCGA) and bioinformatics.
Li CY; Zhang WW; Xiang JL; Wang XH; Li J; Wang JL
Chin Med J (Engl); 2019 Sep; 132(18):2213-2222. PubMed ID: 31490264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
